Both peptides significantly increase IGF-1 (80-100 percent for Tesamorelin, similar for CJC-1295 DAC), but with radically different kinetics: daily injection for Tesamorelin vs weekly for CJC-1295 DAC
Cost Advantage: Tirzepatide (depending on your insurance) Cost analyses for these drugs can be extremely difficult, especially when insurance gets involved
The Ohio-based researchers also noted an increased risk of developing "other optic nerve disorders," identified in 93 patients
Many competitors limit you to one or the other, but Hims offers both
Known in scientific circles for its role in gastric protection and gastrointestinal support, BPC-157 is being explored for its potential to support gut lining strength, digestion, and balance in the microbiome ecosystem
Older pregnant individuals, as absorption efficiency decreases with age [*]